1. Home
  2. DMAC vs ODV Comparison

DMAC vs ODV Comparison

Compare DMAC & ODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • ODV
  • Stock Information
  • Founded
  • DMAC 2000
  • ODV 2005
  • Country
  • DMAC United States
  • ODV Canada
  • Employees
  • DMAC N/A
  • ODV N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • ODV Precious Metals
  • Sector
  • DMAC Health Care
  • ODV Basic Materials
  • Exchange
  • DMAC Nasdaq
  • ODV Nasdaq
  • Market Cap
  • DMAC 190.2M
  • ODV 182.8M
  • IPO Year
  • DMAC N/A
  • ODV N/A
  • Fundamental
  • Price
  • DMAC $4.36
  • ODV $2.09
  • Analyst Decision
  • DMAC Strong Buy
  • ODV
  • Analyst Count
  • DMAC 2
  • ODV 0
  • Target Price
  • DMAC $7.00
  • ODV N/A
  • AVG Volume (30 Days)
  • DMAC 67.1K
  • ODV 226.6K
  • Earning Date
  • DMAC 11-11-2024
  • ODV 11-06-2024
  • Dividend Yield
  • DMAC N/A
  • ODV N/A
  • EPS Growth
  • DMAC N/A
  • ODV N/A
  • EPS
  • DMAC N/A
  • ODV N/A
  • Revenue
  • DMAC N/A
  • ODV $15,873,306.00
  • Revenue This Year
  • DMAC N/A
  • ODV N/A
  • Revenue Next Year
  • DMAC N/A
  • ODV $245.45
  • P/E Ratio
  • DMAC N/A
  • ODV N/A
  • Revenue Growth
  • DMAC N/A
  • ODV N/A
  • 52 Week Low
  • DMAC $1.94
  • ODV $1.70
  • 52 Week High
  • DMAC $4.95
  • ODV $3.65
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 58.96
  • ODV 46.75
  • Support Level
  • DMAC $4.11
  • ODV $2.12
  • Resistance Level
  • DMAC $4.48
  • ODV $2.25
  • Average True Range (ATR)
  • DMAC 0.20
  • ODV 0.12
  • MACD
  • DMAC -0.00
  • ODV -0.01
  • Stochastic Oscillator
  • DMAC 74.63
  • ODV 20.65

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About ODV Osisko Development Corp.

Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation and development activities of its projects.

Share on Social Networks: